Examining QOL in cancer: how to pick the right sample size

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.287, 2000-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How much for a star? Elements for a rational choice of sample size in preclinical trials

By Haimez C. Groupe Biopharmacie et Sante de la Societe Francaise de Statistique Good preclinical statistical practices working party

Trends in Pharmacological Sciences, Vol. 23, Iss. 5, 2002-05 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

Superior QOL with sunitinib in renal cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 560, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Improved QOL with capecitabine in breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 1033-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Sample Size Calculations for Clinicians

Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. : 35-38

Karger

Access to resources Recommend Favorite